Article in mLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
The geneAntimicrobial agents and chemotherapy · 2025
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Sanshan ZengState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.ORCID 0009-0002-2047-7669
Yanan JuState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.
Md Shah AlamState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.
Ziwen LuState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.
H M Adnan HameedState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.ORCID 0000-0003-1993-9547
Lijie LiState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.
Xirong TianState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.
Cuiting FangState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.
Xiange FangState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.
Jie DingState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Guangzhou China.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A CRISPR-nonhomologous end-joining-based strategy for rapid and efficient gene disruption in · full record | OpenQuestion